new glp-1 receptor agonists Revolutionizing obesity treatment: The emerging role of and next-generation pharmacotherapies Frontiers | GLP-1 Receptor Agonists:

Liraglutide (Victoza / Saxenda) Liraglutide was one of the earlier GLP-1 receptor agonists to reach the market, approved first for diabetes and later for weight loss under the brand name Saxenda

Retatrutide: The Triple Threat Retatrutide is often called the triple agonist because it works on three different hormones at once : GLP-1, GIP, and glucagon

Liver fat reduction This is where retatrutide pulls decisively ahead

Ongoing Research New studies are testing their impact on: Alzheimers disease Cardiovascular protection Inflammatory conditions These drugs might have more uses than we originally thought

Lifestyle: 3045 min post-meal walk, resistance/yoga 34/week, 78 hours sleep, stress management through pranayama, and 2.53 L water daily

Gogebakan, O